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Annexin V is an intracellular protein recently shown to be localized to nucleoli and cytosol. In this study we show that cytosolic annexin V is 
associated with mitochondria. To assess the nature of the annexin V-mitochondrial interaction, an annexin V binding activity was partially purified 
from placental cytosol by annexin V-affinity chromatography. Five polypeptides in the eluate appeared to be associated with annexin V, with a 
predominant species of 27 kDa. Antibodies to the 27 kDa polypeptide recognised mitochondria but not nucleoli. We conclude that annexin V 
interacts with a 27 kDa mitochondrial polypeptide that is possibly part of a larger complex. 
Annexin V, Mitochondrion 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The annexin superfamily consists of a growing num- 
ber of proteins that can be classified into sub-groups on 
the basis of structural similarities and the nature of the 
calcium-dependent phospholipid binding they exhibit 
[I]. Like most other annexins, annexin V has a fourfold 
internal repeat of a hydrophobic 70 amino acid domain 
flanked by short amino and carboxy terminal regions 
[2]. It is a symmetrical molecule that binds 5 atoms of 
calcium [3], resembles membrane-channel forming pro- 
teins [4], and is a potent anti-phospholipase and antico- 
agulant. Although extensively studied, its true physio- 
logical function is unknown. 
The intracellular and apparently ubiquitous occur- 
rence of annexin V [5,6] suggests that it has a crucial role 
to play at the cellular level. To attempt to elucidate the 
possible function of annexin V we are investigating its 
subcellular distribution. In a previous study we showed 
that it is located in the nucleoli and cytosol of a variety 
of cell lines, and suggested that this distribution is con- 
sistent with a role in ribosomal assembly and transport 
[6]. In this study we have examined the cytosolic distri- 
bution of annexin V in more detail and find that it is 
associated with mitochondria. Partial purification of 
interacting proteins by affinity chromatography sug- 
gests that annexin V binds to a 27 kDa mitochondrial 
polypeptide that is probably part of a larger protein 
complex. 
Correspondence address: P. Bird, Department of Medicine, Clive 
Ward Centre, Box Hill Hospital, Box Hill 3128, Australia. Fax: (61) 
(3) 895 0332. 
Published by Elsevier Science Publishers B. V 
2.1. Cells and antibodies 
A549 cells were purchased from the ATCC and cultured as de- 
scribed previously [6]. Anti-annexin V antibody was prepared and 
aBinity purified as before [6]. A hybridoma culture supematant con- 
taining a monoclonal antibody recognising human mitochondria 
(MAB1273) was purchased from Chemicon International Inc., USA. 
2.2. Preparation of mitochondria 
Approximately IO’ A549 cells were washed and resuspended in 500 
~110 mM Tris pH 8.0,l mM MgCl,. After 15 min on ice the suspen- 
sion was subjected to 10-12 strokes of a Dounce homogenizer and 
added to 500 ~140 mM Tris pH 8.0,0.3 M sucrose, 2 mM MgCl,. The 
homogenate was fractionated by differential centrifugation according 
to Nigam and Blobel [7j. The post-nuclear supematant from this 
procedure was subjected to 10,000 x g for 10 min to pellet the mito- 
chondria. The pellet was resuspended in the same buffer, re-centri- 
fuged, and assayed for the mitochondrial marker enzyme, cytochrome 
c oxidase [8], and a cytosolic enzyme, lactate dehydrogenase [9]. Mito- 
chondria were lysed by the addition of 1% (v/v) Triton X-100. 
2.3. Immunoassays 
Immunoblotting and indirect immunofluorescence were performed 
as described [6], except hat in the latter technique cells were fixed and 
permeabilized for 3 min in ice-cold acetone/methanol (1: 1, v/v). Fluo- 
rescein isothioscyanate (FITC) labeled annexin V was prepared and 
used as previously described [q. Fluorescence microscopy was per- 
formed using an Olympus BH2 microscope. Samples labeled with both 
FITC and rhodamine isothiocyanate (RITC) were visualized with a 
supplementary barrier filter in place. This filter reduces the intensity 
of the FITC signal but prevents the RITC fluorescence overlapping 
with the FITC fluorescence. Immunoprecipitations (200 ~1 total vol- 
ume) were performed by the addition of 10 &ml of affinity purified 
annexin V antibodies to a sample (0.5 j@ml) of iodinated eluate, in 
the presence or absence of 1 @ml annexin V. Following 4 h at 4°C 
2.5% (w/v) protein A sepharose (Pharmacia) was added and the incu- 
bation continued for 2 h. Complexes were collected by centrifugation 
and washed three times in 50 mM Tris pH 8.0,150 mM NaCl, 5 mM 
EDTA, 0.25% (w/v) gelatin, 0.05% (v/v) Nonidet P40 prior to analysis 
by SDS-PAGE. 
2.4. Annexin V gel shift assay 
Purified annexin V [6,10] was labeled with Na-“‘Iodine (NEN Du- 
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Pont) using Iodogen (Pierce Chemical Co.). The iodinated protein, 
with or without the addition of other compounds, was then subjected 
to 7.5% non-denaturing (non-dissociating continuous buffer system) 
polyacrylamide gel electrophoresis [l l] and autoradiography. 
2.5. Partial puriJication of annexin V binding proteins 
An affinity column consisting of 20 mg of pure annexin V coupled 
to 10 ml Affigel-15 (Bio-Rad) was prepared according to the manufac- 
turer’s instructions. 500 ml of human placental cytosolic extract [12] 
(5 mg/ml total protein, in a buffer consisting of 10 mM imidazole pH 
7.20.25 M sucrose, 5 mM ~-me~apt~thanol, 3mM MgCl,, I mM 
EDTA, 1% (v/v) Triton X-100) was applied to thecolumn. The column 
was washed extensively with 20 mM Tris pH 7.0, 0.5 M NaCl and 
protein remaining on the column duted with 20 mM Tris pH 7.0, 2 
M NaCl, 1% (v/v) Triton X-100. Fractions were assayed for annexin 
V binding activity using the gel shift assay, and those showing peak 
activity were pooled, subjected to SDS-PAGE, and stained with 0.1% 
(w/v) Coomassie Blue in 10% (v/v) methanol, 0.5% (v/v) acetic acid. 
A band corresponding to a 27 kDa polypeptide was excised from the 
gel, emulsified in marcol/montanide oil (9: 1, v/v) and used to immunize 
rabbits [13]. 
Fig. 1. Association of annexin V with mitochondria. Solvent-fixed and 
permeabilized A549 cells were simultaneously stained with 1 &ml 
FITC-conjugated annexin V (upper panel) and a 1:200 dilution of an 
anti-mitochondrial monoclonal antibody (lower panel). The monoclo- 
nal was visualized following incubation with a 1:200 dilution of a 
RITC-conjugated anti-mouse IgG second antibody (Silenus, Austra- 
Purified mitochondria were lysed, the mitochondrial 
proteins were separated by SDS-PAGE, and then tested 
by immunoblotting for the presence of annexin V using 
affinity-purified anti-annexin V antibodies. As shown in 
Fig.2A, a unique band of 35 kDa was observed on the 
immunoblot, confirming that annexin V is associated 
with mitochondria. 
lia). Note the nucleolar staining on incubation with annexin V. To show that ~tochond~a contain an annexin V 
3. RESULTS 
3.1. Localization of annexin V to mitochondria by JEuo- 
rescence microscopy 
We have previously used indirect immunofluores- 
cence to show that annexin V is located in the nucleolus 
and cytosol of many cell lines. Strong staining was ob- 
served in the cytoplasm, which obscured many of the 
intra~llular structures and rendered the nucleolar 
staining almost invisable [6]. Given the phospholipid 
binding properties of annexin V, we wondered whether 
part of this strong cytoplasm& staining represents an- 
nexin V bound to phospholipid. To test this we altered 
our fixing procedure from treatment with formaldehyde 
(which cross-links phospholipid) to treatment with ace- 
tone/methanol (which solubilizes and removes phos- 
pholipid). Indirect fluorescent staining of solvent-fixed 
A549 cells with affinity-purified anti-annexin V anti- 
bodies revealed a greatly diminished intensity of cy- 
tosolic staining and a clear, intracellular, punctate pat- 
tern reminiscent of mit~hondria (data not shown). 
To confirm that annexin V localizes to ~t~hondria, 
we incubated solvent-fixed cells with pun%ed annexin V 
conjugated to FITC in a double-labeling experiment 
that also included a monoclonal antibody recognising 
mitochondria (and subsequently marked with an anti- 
mouse RITC-conjugated antibody). As shown in Fig. 1, 
with the exception of the nucleolar staining we have 
previously reported, the pattern of annexin V staining 
was clearly coincident with that observed for the mono- 
clonal antibody, suggesting strongly that annexin V also 
binds to ~t~ho~~a. Staining of mitochondria with 
FITC-ladled annexin V was not calcium dependent, 
and could be abolished by the addition of excess unla- 
beled annexin V (data not shown). 
3.2. Demonstration of annexin V and annexin V-binding 
activity in mitochondrial lysates 
To investigate the association of annexin V with mito- 
chondria, we purified mitochondria from cultured A549 
cells [7]. The purity of the mitochondrial preparations 
was assessed by testing for the presence of cytochrome 
c oxidase (mitochondrial marker) and lactate dehydro- 
genase (cytosolic marker). The mit~hondri~ pellet 
routinely contained 80-100 U cytochrome c oxidaselmg 
protein and 15-20 U lactate dehydrogenase/mg protein. 
By contrast, the supematant contained 5-10 U cyto- 
chrome c oxidase/mg protein and 900-1,000 U lactate 
dehydrogenase/mg protein. 
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Fig. 2. (A) ~~~tmti~ of annexin V in ~t~~a~ &sates. 5 fig ~t~ond~~ protein {lane 1) or 100 ng puritied annexin V (lane 2) were 
separated on 12% SDS-PAGE gels and transferred to nit~l~o~= The membrane was probed w&b 2 ptg$ml aflkity purified ~ti-~ne~n V 
antibodies, and asps using a horse-radish ~ro~d~nju~t~ second antibody and ~~or~~-~ap~o~ development system (Bio-Rad). 
(B) Annexin binding activity in rn~t~o~~a. 3 nh3 ‘?J-annexin V was incubated witbout (lane 2) or with 2#g mitocbondrial protein (lanes l,?) 
for 1 h at 37”C, in the presence of 5 mM EDTA (lane f) or 2.5 m&i cakium @me 3). Samples were subject& to no~~~atin~ ekctrophoresis 
on 7.5% PAGE gels followed by autora~o~apby. Tire verticd arrow shows the direction of migration of samples. 
binding activity, and to determine whether it is likely to 
be a phospholipid or protein, mitochondrial lysates 
were incubated with lz51-labeled annexin V and sub- 
jected to non-dissociating (native) gel electrophoresis. 
In this system, annexin V in the presence of calcium and 
phospholipid does not enter the gel, whereas free an- 
nexin V does (unpublisb~ data). As shown in Fig, 2B, 
annexin V incubated with mitochondrial protein en- 
tered the gel but migrated more slowly than annexin V 
alone. This alteration in mobility was observed in the 
absence and presence of calcium, suggesting that it is 
probably due to a calcium-independent protein-protein 
interaction, rather than a calcium-dependent annexin 
V-phospholipid interaction. 
3.3. Partial purification of annexin V bind&g proteins 
from human platen ta 
To investigate the nature of this annexin V binding 
activity, it was partially purified from the su~~atant 
(cytosolic fraction) of a 4g,~ x g ~n~fugation of 
post-nuclear placental extracts prepared as described 
[12]. The cytosol was passed over an annexin V affinity 
column, the column was washed extensively in the pres- 
ence of 0.5 M N&l, then eluted using 2 M NaCl. Frac- 
tions were collected and assayed for the ability to alter 
the mobility of ‘2SI-labeled annexin V in native gels. 
Fractions showing peak annexin V binding activity were 
analysed by SDS-PAGE. On Coomassie stained gels, up 
to five major polypeptide species were observed in these 
fractions (data not shown). 
To determine which of these polypeptides interacted 
with armexin V, a sample of the peak fraction was iodi- 
nated and used in a simple immunoprecipitation exper- 
iment. The labeled eluate was mixed with unlabeled 
annexin V, immunoprecipitated with anti-annexin V an- 
tibodies, washed extensively, then analysed by SDS- 
PAGE and autoradio~aphy. As shown in Fig. 3 (lane 
I . *r 
+2?k 
Fig. 3. Immunopmcipitation of annexin V-associating proteins from 
affinity purification ehtate. Iodinated luate (lane 1) was mixed with 
unlabeled annexin V and protein A (lane 2), or aSinity-purified anti- 
annexin V antibodies and protein A (lane 3). or unlabeled annexin V, 
antibodies and protein A (lane 4). Samples were analyzed by 10% 
SDS-PAGE followed by autoradio~raphy. 
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Fig. 4. Intracellular localization of the 27 kDa polypeptide. Fixed and permeabilized A549 cells were incubated with a 1:200 dilution of rabbit 
pre-immune serum (upper left) or a 1:200 dilution of immune serum raised against he 27 kDa polypeptide (upper right). The same cells were also 
incubated with a 1:200 dilution of the monoclonal antibody (lower left and right). Rabbit antibodies were marked with a FITC-conjugated second 
antibody, while the monoclonal was marked with a RITC-conjugated second antibody. 
l), besides material that did not enter the gel or ran at 
the dye front, the predominant band in the labeled elu- 
ate prior to immunoprecipitation was at 70 kDa, which 
did not correspond to any of the major polypeptide 
species previously observed in the peak fraction. How- 
ever, eluate samples incubated with unlabeled annexin 
V and protein A (lane 2) or annexin V antibodies and 
protein A (lane 3) showed no bands on the gel. By 
contrast, eluate incubated with unlabeled annexin V, 
anti-annexin V antibodies and protein A (lane 4) re- 
sulted in a reduction in the intensity of the 70 kDa band 
and the appearance of bands at 62 kDa, a doublet at 55 
kDa, 45 kDa, and 27 kDa, with the major species at 27 
kDa. In addition there was enhancement of the amount 
of material that did not enter the gel or migrated at the 
dye front. 
One interpretation of this result is that annexin V 
binds to a 27 kDa component of a protein complex. 
This explains the simultaneous appearance of several 
bands apparently associated with annexin V, the selec- 
tive enhancement of the 27 kDa band, and the appear- 
ance of high MW material @dissociated complex or 
aggregates} that does not enter the gel. 
If the 27 kDa band does bind armexin V, we predicted 
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that it should be associated with ~t~hond~a. To test 
this prediction we separated the polypeptides in the 
peak fraction from the affinity purification by SDS- 
PAGE, excised the 27 kDa band from the gel and used 
it to immunize a rabbit. The resulting antiserum was 
then used in indirect immunofluorescence experiments 
on A549 cells. As shown in Fig. 4, cells incubated with 
both the anti-27 kDa antiserum and the anti-mitochon- 
drial monoclonal antibody showed a coincident pattern 
of staining. Neither the 27 kDa antiserum nor the mon- 
oclonal antibody stained nucleoli. This is consistent 
with a ~tochond~al l~l~ation of the 27 kDa pol- 
ypeptide, and supports the view that it is associated with 
annexin V in mitochondria but not in nucleoli. 
4. DISCUSSION 
Although all annexins share the property of calcium- 
dependent phospholipid binding, physiological roles 
have been suggested for only three of the more than 13 
members of the family. These are annexin II which 
participates in calcium-dependent exocytosis [ 141; an- 
nexin III, which is an inositol 1,2-cyclic phosphate 2- 
phosphohydrola~ [15]; and annexin VI, which is pro- 
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posed to be involved in budding of clath~n~oated en- 
docytic pits [16]. 
The role of annexin V is presently unknown, although 
on the basis of its association of the nucleolus, we have 
suggested that it may function in either the establish- 
ment and maintenance of nucleolar structure, or in ribo- 
some assembly and transport [6]. Our present finding 
that annexin V is also associated with mitochondria 
prompts a re-evaluation of this proposal. Because mito- 
chondria and the nucleolus are structurally distinct it is 
unlikely that annexin V contributes to either organelle 
structur~ly. Likewise, since ~t~hond~a encode their 
own ribosomal RNAs, assemble their own ribosomes, 
and do not transport them, it is unlikely that annexin 
V is involved directly in ribosomal assembly or in the 
transport of completed ribosomes. 
However, one obvious similarity remains between the 
processes of ribosome biosynthesis in both organelles. 
The proteins that are associated with ribosomes bind to 
ribosomal RNA during or very soon after transcription 
and so must be imported from their site of synthesis to 
the site of ribosome assembly. As most of the mitochon- 
drial ribosomal proteins are encoded by nuclear genes, 
a colon requirement of both ~to~hond~al and nu- 
cleolar ribosome assembly is the import of ribosomal 
proteins. A model can therefore be envisaged in which 
annexin V promotes the transport of these proteins to 
the mitochondria and the nucleolus. This model can be 
developed further to take into account the known cal- 
cium-binding properties of annexin V [3,4], to propose 
that it binds or promotes binding of ribosomal proteins 
in the low Ca*+ environment of the cytoplasm. On en- 
countering higher Ca2’ levels in the mitochondria or 
nucleolus, annexin V binds extra Ca2’ ions, undergoes 
a co~o~ational change, and promotes the release of 
the ribosomal proteins. 
In this model the polypeptides that are apparently 
associated with annexin V could be either components 
of the transport apparatus, or passengers. Purification 
and identification of these proteins may enable this issue 
to be addressed. Comparison of these polypeptides with 
nuclear/nucleolar proteins associated with amrexin V 
may also be illuminating since the isolation and identifi- 
cation of the latter proteins was excluded in the present 
studies by our use of post-nuclear cytosoiic prepara- 
tions. At present we can suggest that the 27 kDa pol- 
ypeptide is specific to mitochondria since. antibodies 
recognising it failed to stain nucleoli. 
Finally, this model implies the existence of protein 
transport systems from the cytoplasm to the nucleolus 
and mitochondria. The role of annexin V in such a 
system is consistent with the view that many annexins 
are involved in aspects of protein or vesicular traffick- 
ing [14,16]. It remains to be seen whether the structural 
similarities of distinct annexins translate into related 
physiological roles. 
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